Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb (BMY) has launched a ...

[Editor’s note: The hacker requested that we remove the image for legal reasons, so it’s blurry now. We hope all’s well!] Lithium technology has ushered in a new era of batteries with exceptionally ...

As the FDA steadily churns out a stream of untitled letters chastising pharmaceutical advertisers’ direct-to-consumer ...

After several years of turning out solid growth, Bristol Myers Squibb knows it’s nearing a patent cliff that’ll wreak havoc later this decade. Still, the company believes a “diversified” ...

Biopharmaceutical firm Bristol Myers Squibb (BMS) and IT services company Accenture on Wednesday announced the opening of a new AI-powered content hub, Mosaic, in Mumbai.

Bristol Myers Squibb (BMS) plans to buy out its partner in developing the blockbuster multiple myeloma drug Abecma ® (idecabtagene vicleucel), by agreeing to acquire 2seventy bio for approximately ...

Bristol Myers Squibb has linked its CD19-directed CAR-T cell therapy to sustained clinical responses in people with systemic lupus erythematosus (SLE), providing further evidence that the emerging ...

The latest Fujitsu AIRSTAGE Cloud BMS release, v3.1.4-R4, contains multiple updates and new tools to simplify commissioning ...

BMS Group has announced a strategic partnership with Berns Brett India, signalling its expansion into the Indian market, with ...